At the news
? NEUTRALIMPACT 3/10 144 filed Apr 14, 2026 at 21:17 ET
Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to report a mandatory 'sell to cover' transaction of 37,500 shares to satisfy tax withholding obligations following the vesting of performance-based restricted stock units. This is not a discretionary sale.
- Elizabeth E. Reed, an officer, is reporting a proposed sale of 37,500 common shares.
- The sale is a mandatory 'sell to cover' transaction to fund tax withholding obligations from vested performance restricted stock units.
- The transaction occurred on April 14, 2026, and was not a discretionary trade by the insider.
- Total value of the sale was approximately $1.54 million based on a share price of ~$41.07.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access